Food News and Research

RSS

Allergan completes acquisition of AqueSys

Allergan plc, a leading global pharmaceutical company, today announced that it has successfully completed the acquisition of AqueSys, Inc. a clinical-stage medical device company focused on developing ocular implants that reduce intraocular pressure (IOP) associated with glaucoma.

19 Oct 2015

Sprout announces U.S. availability of Addyi for HSDD treatment in premenopausal women

Sprout Pharmaceuticals, Inc., a division of Valeant Pharmaceuticals North America LLC, announced today that Addyi, a once-daily, non-hormonal pill for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women, is now available in the United States through certified physicians and pharmacies.

19 Oct 2015

Sequenom enters into clinical collaboration with CU School of Medicine

Sequenom, Inc., a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced that it has entered into a clinical collaboration with the University of Colorado Denver, School of Medicine.

19 Oct 2015

TARSA Therapeutics' TBRIA NDA accepted by FDA for review

TARSA Therapeutics, Inc. today announced that its New Drug Application (NDA) for TBRIATM (calcitonin-salmon [rDNA origin] delayed release tablets) submitted to the U.S. Food and Drug Administration (FDA) in July 2015, has been accepted for review, with a PDUFA date of May 30, 2016.

19 Oct 2015

Study could lead to better understanding of metabolic processes behind type 2 diabetes

Scientists in Sweden have discovered that human intestinal flora regulates the levels of the body's main antioxidant, glutathione, which fights a host of diseases. The findings could lead to new probiotic-delivering foods, and a better understanding of the metabolic processes behind diseases such as type 2 diabetes.

19 Oct 2015

Pulsar Vascular reaches target enrollment in PulseRider clinical trial for treatment of intracranial aneurysms

Pulsar Vascular, an innovative medical device company, focused on breakthrough technology in the neurovascular space, announced today that they have reached the target enrollment in their clinical trial for PulseRider, the company's lead product.

19 Oct 2015

Discovery may provide noninvasive approach to assessing toxic effects of anesthetic agents in children

Could looking at the eyes provide a new way of studying how anesthesia affects the developing brain? The retinas of immature mice exposed to one widely used general anesthetic show evidence of "programmed cell death," or apoptosis, reports a study in Anesthesia & Analgesia.

19 Oct 2015

Immatics, UTHealth to partner on cellular manufacturing for adoptive cellular therapy clinical trials

Immatics US, Inc., a subsidiary of Immatics Biotechnologies GmbH, and The University of Texas Health Science Center at Houston will collaborate on cellular manufacturing for adoptive cellular therapy (ACT) clinical trials.

19 Oct 2015

UAMS researchers report positive results from treating Metastatic Merkel-cell carcinoma with idelalisib drug

Identifying a patient's genetic mutation led University of Arkansas for Medical Sciences (UAMS) physician-researcher Ling Gao, M.D., Ph.D., to an existing drug that eliminated the patient's stage IV Merkel-cell carcinoma. Gao's findings, made in collaboration with two other UAMS researchers, were published today in The New England Journal of Medicine.

19 Oct 2015

UCSF scientists urge hospitals to buy only antibiotic-free meat to help stop spread of antibiotic resistance

To help stop the spread of antibiotic resistance, UC San Francisco scientists are urging hospitals around the country to stop buying meat from animals that were given antibiotics for growth promotion.

19 Oct 2015

New study provides first clinical evidence on the serious toll human trafficking has on mental health

A new study by researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London provides the first clinical evidence on the toll human trafficking has on mental health, including high levels of post-traumatic stress disorder (PTSD) and depression, amongst a patient population in South London.

19 Oct 2015

Pediatricians to discuss children's health issues at AAP National Conference & Exhibition

An expected 10,000 pediatricians and other health care professionals will gather in the nation's capital October 24-27 to deepen their knowledge and widen their scope on child advocacy at the American Academy of Pediatrics National Conference & Exhibition.

19 Oct 2015

FDA grants accelerated approval to Praxbind (idarucizumab)

The U.S. Food and Drug Administration today granted accelerated approval to Praxbind (idarucizumab) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations when there is a need to reverse Pradaxa's blood-thinning effects.

19 Oct 2015

More research needed on commercially available nutrigenomics tests: Study

There is insufficient scientific evidence to support the utility of commercially available nutrigenomics tests that claim to link genetic variants to dietary intake or nutrition-related disorders.

19 Oct 2015

University of Maryland develops GammaPod system to treat early-stage breast cancer

After more than a decade of research and development, researchers in the Department of Radiation Oncology at the University of Maryland School of Medicine will begin enrolling patients in the first clinical trial of GammaPod, a new high-precision, image-guided radiation therapy system specifically designed to treat early-stage breast cancer.

19 Oct 2015

New UCL study highlights genes associated with schizophrenia and obesity

Genes involved in schizophrenia and obesity have been highlighted in a new UCL study, which could lead to a better understanding of the DNA variants which affect risk of these conditions and aid the development of improved strategies for prevention and treatment.

18 Oct 2015

ViewRay obtains Korean regulatory approval for MRI-guided radiation therapy system

ViewRay, Inc. announced today that the company has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) – formerly known as the Korean Food and Drug Administration – to sell its ViewRay system in Korea. On October 13, 2015, the first patient treatments commenced less than four weeks after the system completed installation at Seoul National University Hospital, a leading healthcare facility in Korea.

18 Oct 2015

Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)

Boehringer Ingelheim Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration granted approval of Praxbind (idarucizumab). PRAXBIND is indicated for patients treated with Pradaxa (dabigatran etexilate mesylate), when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures or in life-threatening or uncontrolled bleeding.

16 Oct 2015

UM SOM researchers to initiate first clinical trial of GammaPod system in patients with early-stage breast cancer

16 Oct 2015

Two-Level IDE approval granted to Simplify Medical’s cervical artificial disc

Simplify Medical, Inc. is pioneering disc arthroplasty with the non-metal, MRI compatible Simplify™ Disc, a cervical artificial disc.

16 Oct 2015

Food News and Research

Allergan completes acquisition of AqueSys

Sprout announces U.S. availability of Addyi for HSDD treatment in premenopausal women

Sequenom enters into clinical collaboration with CU School of Medicine

TARSA Therapeutics' TBRIA NDA accepted by FDA for review

Study could lead to better understanding of metabolic processes behind type 2 diabetes

Pulsar Vascular reaches target enrollment in PulseRider clinical trial for treatment of intracranial aneurysms

Discovery may provide noninvasive approach to assessing toxic effects of anesthetic agents in children

Immatics, UTHealth to partner on cellular manufacturing for adoptive cellular therapy clinical trials

UAMS researchers report positive results from treating Metastatic Merkel-cell carcinoma with idelalisib drug

UCSF scientists urge hospitals to buy only antibiotic-free meat to help stop spread of antibiotic resistance

New study provides first clinical evidence on the serious toll human trafficking has on mental health

Pediatricians to discuss children's health issues at AAP National Conference & Exhibition

FDA grants accelerated approval to Praxbind (idarucizumab)

More research needed on commercially available nutrigenomics tests: Study

University of Maryland develops GammaPod system to treat early-stage breast cancer

New UCL study highlights genes associated with schizophrenia and obesity

ViewRay obtains Korean regulatory approval for MRI-guided radiation therapy system

Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)

UM SOM researchers to initiate first clinical trial of GammaPod system in patients with early-stage breast cancer

Two-Level IDE approval granted to Simplify Medical’s cervical artificial disc

The future is bioengineered: Synthetic biology and global sustainability eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News